I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Risk of diverticulitis and gastrointestinal perforation in ..:
Rempenault, Claire
;
Lukas, Cédric
;
Combe, Bernard
...
info:eu-repo/semantics/altIdentifier/doi/10.1093/rheumatology/keab438. , 2022
Link:
https://hal.science/hal-03619916
RT Journal T1
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept
UL https://suche.suub.uni-bremen.de/peid=base-ftinserm:oai:HAL:hal-03619916v1&Exemplar=1&LAN=DE A1 Rempenault, Claire A1 Lukas, Cédric A1 Combe, Bernard A1 Herrero, Astrid A1 Pane, Isabelle A1 Schaeverbeke, Thierry A1 Wendling, Daniel A1 Pham, Thao A1 Gottenberg, Jacques-Eric A1 Mariette, Xavier A1 Morel, Jacques PB HAL CCSD; Oxford University Press (OUP) YR 2022 K1 rheumatoid arthritis K1 tocilizumab K1 diverticulitis K1 gastrointestinal perforation K1 MESH: Abatacept / adverse effects K1 MESH: Antibodies K1 Monoclonal K1 Humanized / adverse effects K1 MESH: Intestinal Perforation / etiology K1 MESH: Male K1 MESH: Middle Aged K1 MESH: Registries K1 MESH: Rituximab / adverse effects K1 MESH: Antirheumatic Agents / adverse effects K1 MESH: Arthritis K1 Rheumatoid / drug therapy K1 MESH: Diverticulitis / epidemiology K1 MESH: Diverticulitis / etiology K1 MESH: Female K1 MESH: France / epidemiology K1 MESH: Humans K1 MESH: Intestinal Perforation / epidemiology K1 [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system K1 [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy K1 [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology JF info:eu-repo/semantics/altIdentifier/doi/10.1093/rheumatology/keab438 LK http://dx.doi.org/https://hal.science/hal-03619916 DO https://hal.science/hal-03619916 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)